Chemotherapy with paclitaxel for recalcitrant molluscum contagiosum in an HIV-infected patient.
HIV / AIDS
dermatology
skin
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
10 Jun 2021
10 Jun 2021
Historique:
entrez:
11
6
2021
pubmed:
12
6
2021
medline:
16
6
2021
Statut:
epublish
Résumé
Molluscum contagiosum (MC) is a viral skin infection seen in children, sexually active adults and immunocompromised populations. It is usually a self-limiting illness that typically spontaneously resolves without therapeutic intervention. However, when the papules are extensive or refractory causing complications or aesthetic issues, multiple treatment modalities exist to relieve symptoms, limit spread and decrease the social stigma associated with visible lesions. Treatment is especially important in HIV/AIDS infected populations, where prevalence is estimated between 5% and 18% and susceptibility to larger, widespread and recalcitrant lesions involving atypical distributions is more common. We evaluated a 38-year-old woman with a history of AIDS (CD4+ T cell count <25 cells/µL) and poor adherence with antiretroviral therapy who presented with a 9-month history of persistent, progressively worsening facial and truncal umbilicated papules consistent with recalcitrant MC refractory to cidofovir injections. She was successfully treated with paclitaxel with complete resolution of the lesions after four cycles without adverse effects.
Identifiants
pubmed: 34112632
pii: 14/6/e240776
doi: 10.1136/bcr-2020-240776
pmc: PMC8194322
pii:
doi:
Substances chimiques
Cidofovir
JIL713Q00N
Paclitaxel
P88XT4IS4D
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Clin Cosmet Investig Dermatol. 2019 May 30;12:373-381
pubmed: 31239742
Mol Biol Cell. 2014 Sep 15;25(18):2677-81
pubmed: 25213191
Pediatr Dermatol. 2005 Jul-Aug;22(4):287-94
pubmed: 16060861
Actas Dermosifiliogr (Engl Ed). 2018 Jun;109(5):408-415
pubmed: 29576186
Pediatr Dermatol. 2010 Jul-Aug;27(4):388-94
pubmed: 19804497
Cochrane Database Syst Rev. 2017 May 17;5:CD004767
pubmed: 28513067
Top HIV Med. 2010 Dec;18(5):169-72
pubmed: 21245518
JAAD Case Rep. 2020 Jun 17;6(8):708-709
pubmed: 32715056
Dermatol Ther. 2013 Nov-Dec;26(6):445-51
pubmed: 24552407
Expert Opin Drug Saf. 2007 Sep;6(5):609-21
pubmed: 17877447
Hautarzt. 1997 Feb;48(2):103-9
pubmed: 9173055
Lancet Infect Dis. 2013 Oct;13(10):877-88
pubmed: 23972567
Pharm World Sci. 2005 Dec;27(6):423-31
pubmed: 16341948
Indian J Dermatol Venereol Leprol. 2017 Mar-Apr;83(2):265-266
pubmed: 27853002
Pediatr Dermatol. 2011 May-Jun;28(3):254-8
pubmed: 21615471
EMBO J. 2000 Aug 1;19(15):3932-44
pubmed: 10921875
Dermatol Clin. 2006 Oct;24(4):473-95, vi
pubmed: 17010777